Researchers developed an electrochemical biosensor and AI system that accurately detects lung cancer from breath samples.
Key Details
- 1University of Texas at Dallas and UT Southwestern developed an electrochemical biosensor for breath analysis.
- 2The technology uses AI to analyze eight volatile organic compounds linked to thoracic cancers.
- 3In a study with 67 patients (30 biopsy-confirmed cancers), the device identified cancer-linked VOCs with 90% accuracy.
- 4The approach is designed for early, noninvasive, and affordable screening of lung and esophageal cancers.
- 5The technology was reported in the August issue of Sensing and Bio-Sensing Research.
Why It Matters
This innovation could enable routine, noninvasive, and cost-effective early detection of lung and other thoracic cancers, potentially improving survival rates and reducing burdens on healthcare systems. The integration of machine learning in biosensing highlights the expanding role of AI in clinical cancer diagnostics.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.